MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Avinger Operating Income 2011-2026 | AVGR
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.6 M | -16 M | -18.1 M | -17.4 M | -19.4 M | -23 M | -42.6 M | -50.7 M | -40.7 M | -25 M | -37 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -16 M | -50.7 M | -27.9 M |
Quarterly Operating Income Avinger
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.67 M | -4.13 M | -5.09 M | - | -4.03 M | -3.73 M | -4.26 M | - | -3.68 M | -3.76 M | -4.7 M | - | -4.49 M | -4.41 M | -4.65 M | - | -4.1 M | -3.59 M | -5.48 M | - | -4.62 M | -4.71 M | -5.03 M | - | -5.36 M | -5.71 M | -5.88 M | - | -8.87 M | -11.3 M | -13.8 M | - | -11.4 M | -12.3 M | -15 M | - | -9.88 M | -9.08 M | -9.42 M | - | -6.14 M | -5.53 M | -6.38 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -3.59 M | -15 M | -6.49 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
230 M | - | - | $ 17.2 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-136 M | $ 20.67 | -1.76 % | $ 2.95 B | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.52 | 0.57 % | $ 122 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 8.91 | -5.21 % | $ 640 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
2.6 B | $ 94.77 | -0.63 % | $ 139 B | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 304.72 | 0.42 % | $ 8.6 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 27.78 | -4.4 % | $ 235 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 47.97 | 1.83 % | $ 7.15 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Abbott Laboratories
ABT
|
6.82 B | $ 124.11 | -0.94 % | $ 216 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.31 | 0.61 % | $ 123 M |  France |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
IRadimed Corporation
IRMD
|
22 M | $ 95.52 | -1.81 % | $ 1.21 B | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
InMode Ltd.
INMD
|
113 M | $ 14.91 | 1.46 % | $ 1.18 B | Israel |
 |
LivaNova PLC
LIVN
|
129 M | $ 60.9 | -1.02 % | $ 3.3 B |  Britain |
|
LENSAR
LNSR
|
-10.7 M | $ 11.68 | 0.43 % | $ 135 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 156.64 | 0.31 % | $ 11.7 B | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.85 | 3.09 % | $ 87.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 14.01 | 2.41 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.52 | -0.24 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
-3.29 M | $ 30.97 | -5.38 % | $ 1.37 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.18 | 3.51 % | $ 19 M | USA |
 |
CONMED Corporation
CNMD
|
200 M | $ 40.83 | 0.62 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-35 M | $ 17.7 | -0.32 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
166 M | $ 87.03 | -0.39 % | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 12.02 | -3.22 % | $ 926 M | USA |
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Myomo
MYO
|
-10.7 M | $ 0.96 | 3.31 % | $ 6.77 M | USA |